![Ekkehard Schütz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ekkehard Schütz
Directeur Technique/Scientifique/R&D chez
INSIGHT MOLECULAR DIAGNOSTICS INC.
Profil
Ekkehard Schütz currently works at Chronix Biomedical, Inc., as Chief Executive Officer & Chief Medical Officer, Chronix Biomedical GmbH, as Managing Director from 2011, and Insight Molecular Diagnostics, Inc., as Chief Science Officer from 2022.
Dr. Schütz received his doctorate degree from the University of Gottingen.
Postes actifs de Ekkehard Schütz
| Sociétés | Poste | Début |
|---|---|---|
| INSIGHT MOLECULAR DIAGNOSTICS INC. | Directeur Technique/Scientifique/R&D | 01/04/2021 |
Chronix Biomedical, Inc.
 Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic substances chemicals | Directeur Général | - |
Chronix Biomedical GmbH | Corporate Officer/Principal | 01/04/2011 |
Formation de Ekkehard Schütz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Chronix Biomedical, Inc.
Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic substances chemicals | Health Technology |
University of Gottingen
 University of Gottingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoCyte Corp.
 OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
Chronix Biomedical GmbH |
